SLC18A2 Antibody | 29-914

SLC18A2 Antibody | 29-914 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse

Homology: N/A

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human SLC18A2.

Research Area: Membrane, Cancer

Tested Application: E, WB

Application: SLC18A2 antibody can be used for detection of SLC18A2 by ELISA at 1:312500. SLC18A2 antibody can be used for detection of SLC18A2 by western blot at 0.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50, 000 - 100, 000.

Specificiy: N/A

Positive Control 1: Cat. No. 1205 - Jurkat Cell Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: 56 kDa

Validation: N/A

Isoform: N/A

Purification: Antibody is purified by peptide affinity chromatography method.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Concentration: batch dependent

Storage Condition: For short periods of storage (days) store at 4˚C. For longer periods of storage, store SLC18A2 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Alternate Name: SLC18A2, MGC120477, MGC120478, MGC26538, SVAT, SVMT, VAT2, VMAT2

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine.